America as we know it was built largely upon and because of our rail industry, and today it remains…
So-Called "Railway Safety Act" Constitutes a Political Handout to Big Labor That Does Nothing to Improve Safety At All
America as we know it was built largely upon and because of our rail industry, and today it remains a pillar of our economy.
Unfortunately, a destructive proposal before Congress misleadingly named the "Railway Safety Act" (RSA), part of broader surface transportation reauthorization, threatens great harm to our railroads.
Simply put, the bill has nothing to do with improving safety, but has a lot to do with advancing the political agenda of Big Labor. At a moment when inflation burdens American families and fragile supply chains remain vulnerable to disruption, the last thing our economy or rail sector need is another costly federal mandate imposed upon one of the nation’s most important transportation sectors.
As an initial matter, as noted by The Wall Street Journal, the…[more]
Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses the history and regulations surrounding drug prices, who should finance important medical advancements, and the continuing Zika threat.
Sally Pipes, President and CEO of Pacific Research Institute, discusses her recently released book, “The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy and How to Keep It,” the horrible impacts of price controls, how single-payer healthcare systems fail children and cancer patients, and more.
In an interview with CFIF, William Conti, an attorney in Washington, D.C., discusses the first debate between former President Trump and Vice President Harris, the impact of endorsements, the status of the fight for the Senate in 2024, and the Republican bench looking forward to 2028.
Sally Pipes, Founder and President of Pacific Research Institute, discusses the impact of drug price controls under the Inflation Reduction Act (IRA), what it means for research and development of life-saving medicines, and how the IRA's drug pricing provisions will reduce access to new cures and treatments and result in longer wait times for existing medicines.
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.
William J. Conti, an Attorney from Washington, DC, discusses some of the U.S. Senate races to watch this year, the impact voter turnout for the presidential race may have on the Congressional races, and what Robert F. Kennedy, Jr.'s presidential run might mean for the other candidates.
Pat Rosenstiel, Founder and Chairman of the Trade Alliance to Promote Prosperity, discusses HHS's proposal to create an "International Pricing Index" payment model for prescription drugs administered under Medicare Part B, why this proposal is bad for Americans and how it will hurt research and development of new drugs.